|
Name |
methyl (2Z,3E,5E,7E,9E)-2-ethylidene-11-[(1S,5S)-4-hydroxy-4-(2-hydroxyethyl)-2-oxo-6-oxa-3-azabicyclo[3.1.0]hexan-1-yl]-4,10-dimethyl-11-oxoundeca-3,5,7,9-tetraenoate
|
| Molecular Formula | C22H27NO7 | |
| IUPAC Name* |
methyl (2Z,3E,5E,7E,9E)-2-ethylidene-11-[(1S,5S)-4-hydroxy-4-(2-hydroxyethyl)-2-oxo-6-oxa-3-azabicyclo[3.1.0]hexan-1-yl]-4,10-dimethyl-11-oxoundeca-3,5,7,9-tetraenoate
|
|
| SMILES |
C/C=C(/C=C(\C)/C=C/C=C/C=C(\C)/C(=O)[C@]12[C@H](O1)C(NC2=O)(CCO)O)\C(=O)OC
|
|
| InChI |
InChI=1S/C22H27NO7/c1-5-16(18(26)29-4)13-14(2)9-7-6-8-10-15(3)17(25)22-19(30-22)21(28,11-12-24)23-20(22)27/h5-10,13,19,24,28H,11-12H2,1-4H3,(H,23,27)/b8-6+,9-7+,14-13+,15-10+,16-5-/t19-,21?,22-/m1/s1
|
|
| InChIKey |
OHWILISHWFHITP-MMHCRKMISA-N
|
|
| Synonyms |
NG-393
|
|
| CAS | NA | |
| PubChem CID | 101544227 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 417.5 | ALogp: | 2.4 |
| HBD: | 3 | HBA: | 7 |
| Rotatable Bonds: | 10 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 126.0 | Aromatic Rings: | 2 |
| Heavy Atoms: | 30 | QED Weighted: | 0.17 |
| Caco-2 Permeability: | -4.715 | MDCK Permeability: | 0.00002010 |
| Pgp-inhibitor: | 0.996 | Pgp-substrate: | 0.022 |
| Human Intestinal Absorption (HIA): | 0.555 | 20% Bioavailability (F20%): | 0.962 |
| 30% Bioavailability (F30%): | 0.981 |
| Blood-Brain-Barrier Penetration (BBB): | 0.954 | Plasma Protein Binding (PPB): | 80.71% |
| Volume Distribution (VD): | 1.6 | Fu: | 12.43% |
| CYP1A2-inhibitor: | 0.034 | CYP1A2-substrate: | 0.633 |
| CYP2C19-inhibitor: | 0.039 | CYP2C19-substrate: | 0.448 |
| CYP2C9-inhibitor: | 0.054 | CYP2C9-substrate: | 0.032 |
| CYP2D6-inhibitor: | 0.001 | CYP2D6-substrate: | 0.117 |
| CYP3A4-inhibitor: | 0.022 | CYP3A4-substrate: | 0.77 |
| Clearance (CL): | 3.471 | Half-life (T1/2): | 0.849 |
| hERG Blockers: | 0.119 | Human Hepatotoxicity (H-HT): | 0.683 |
| Drug-inuced Liver Injury (DILI): | 0.858 | AMES Toxicity: | 0.944 |
| Rat Oral Acute Toxicity: | 0.516 | Maximum Recommended Daily Dose: | 0.947 |
| Skin Sensitization: | 0.941 | Carcinogencity: | 0.791 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.01 |
| Respiratory Toxicity: | 0.398 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC002117 | ![]() |
1.000 | D0FG6M | ![]() |
0.255 | ||
| ENC005164 | ![]() |
0.569 | D05QDC | ![]() |
0.239 | ||
| ENC005165 | ![]() |
0.569 | D00DKK | ![]() |
0.239 | ||
| ENC001936 | ![]() |
0.569 | D02DGU | ![]() |
0.239 | ||
| ENC003853 | ![]() |
0.327 | D0G3PI | ![]() |
0.239 | ||
| ENC003854 | ![]() |
0.327 | D0B1IP | ![]() |
0.228 | ||
| ENC003852 | ![]() |
0.297 | D0S7WX | ![]() |
0.211 | ||
| ENC003807 | ![]() |
0.278 | D0E9KA | ![]() |
0.190 | ||
| ENC003585 | ![]() |
0.278 | D0MY8N | ![]() |
0.172 | ||
| ENC005401 | ![]() |
0.266 | D0H2MO | ![]() |
0.166 | ||